Lexeo Therapeutics thinks its gene therapy has the potential for accelerated approval following positive interim data from ...
Clinical-stage cell therapy developer Artiva Biotherapeutics will seek about $116 million in net proceeds from its proposed ...
GSK is mov­ing its glob­al head­quar­ters clos­er to where it all start­ed. The UK drug­mak­er is for­mal­ly shift­ing Tues­day in­to a brand new build­ing at … ...
The UK’s cen­ter-left Labour Par­ty won a land­slide vic­to­ry at last week’s gen­er­al elec­tion, end­ing the cen­ter-right ...
An experimental BTLA agonist that Eli Lilly cut from its pipeline for lupus late last year failed to show strong enough ...
Novo Nordisk’s once-weekly insulin has been turned down by the FDA, and the Danish pharma likely won't be refiling until next ...
The chief scientific officer at gene editing company Metagenomi is out, the company confirmed to Endpoints News.
Ipsen is adding a second antibody-drug conjugate to its plate. The French drugmaker said Thursday that it has inked a global ...
Roche’s Spark Ther­a­peu­tics is let­ting staffers go and has “dis­con­tin­ued” sev­er­al ear­ly-stage pro­grams, a ...
The blank-check acquisition companies Launch One Acquisition and SIM Acquisition went public this week, a signal that the ...
Scientists have discovered a hormone responsible for keeping bones sturdy in lactating people and mice, which could have ...
The Supreme Court's decision late last month to overrule a decades-old legal doctrine will have major ramifications for the ...